| Darren D Chao, MD | |
|
433 W High St, Bryan, OH 43506-1690 | |
| (419) 636-1131 | |
| Not Available |
| Full Name | Darren D Chao |
|---|---|
| Gender | Male |
| Speciality | Radiology - Diagnostic Radiology |
| Location | 433 W High St, Bryan, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063480663 | NPI | - | NPPES |
| 2168934 | Medicaid | OH | |
| 300108868 | Other | OH | RAILROAD MEDICARE |
| 000000135702 | Other | OH | ANTHEM BCBS |
| 300108869 | Other | OH | RAILROAD MEDICARE |
| 4235800 | Medicaid | MI | |
| 300108867 | Other | OH | RAILROAD MEDICARE |
| 4300945 | Medicaid | MI | |
| 300108870 | Other | OH | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 35.077637 (Ohio) | Primary |
| 208D00000X | General Practice | 35.077637 (Ohio) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Darren D Chao, MD Po Box 1046, Lima, OH 45802-1046 Ph: (419) 224-5707 | Darren D Chao, MD 433 W High St, Bryan, OH 43506-1690 Ph: (419) 636-1131 |
News Archive
Celgene International Sàrl, a subsidiary of Celgene Corporation today announced that the U.S. Food and Drug Administration has assigned a Priority Review designation to the supplemental New Drug Application for the use of ABRAXANE (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) in combination with gemcitabine for the first-line treatment of patients with advanced pancreatic cancer.
Pfizer Inc today announced new, longer-term data from the Intergroup Exemestane Study (IES) showing that women who switched to AROMASIN® (exemestane tablets) after taking tamoxifen for two to three years experienced a significant reduction (18%) in the risk of disease-free survival (DFS) events. In addition, IES showed that AROMASIN prolonged overall survival (OS) in the ER+/unknown population with a 14% reduction in the risk of dying. These results demonstrate that the benefits of treatment are maintained in long term follow-up. These results were presented at the joint ECCO 15/ESMO 34 meeting in Berlin, Germany.
Response-guided addition of adefovir to lamivudine-based therapy not only maintains long-term viral suppression in Chinese chronic hepatitis B patients with compensated liver cirrhosis, research suggests, but also improves liver function.
Janssen-Cilag International NV announced today that the European Commission has approved the use of VELCADE (bortezomib) as induction therapy (a first therapeutic option) in combination with dexamethasone or thalidomide and dexamethasone. This licence extension will apply to adult patients with previously-untreated multiple myeloma who are eligible for high-dose chemotherapy with haematological stem cell transplantation.
The Cancer Institute of New Jersey (CINJ) is making experts available to discuss the risks, and options for treatment and prevention surrounding breast cancer. According to the American Cancer Society 227,000 women nationwide will be diagnosed with the disease this year, and while the disease affects mostly women, men also can be diagnosed with breast cancer.
› Verified 8 days ago
John P Ewonus, D.O. Radiology Medicare: Accepting Medicare Assignments Practice Location: 433 W High St, Bryan, OH 43506 Phone: 419-636-1131 | |
Usha Sharma, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 433 W High St, Bryan, OH 43506 Phone: 419-636-1131 | |
Dr. Wainwright Anthony Jaggernauth, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 524 W High St, Bryan, OH 43506 Phone: 419-636-9800 Fax: 419-636-0451 | |
Dr. Michael Pak, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 524 W High St, Bryan, OH 43506 Phone: 419-636-9800 |